Bioceres Crop Solutions Corp (BIOX, Financial) is set to release its Q4 2024 earnings on Sep 10, 2024. The consensus estimate for Q4 2024 revenue is $135.36 million, and the earnings are expected to come in at $0.25 per share. The full year 2024's revenue is expected to be $476.08 million and the earnings are expected to be $0.36 per share. More detailed estimate data can be found on the Estimates page.
Bioceres Crop Solutions Corp (BIOX, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Bioceres Crop Solutions Corp (BIOX) for the full year 2024 have decreased from $477.7 million to $476.08 million. For 2025, the estimates have been revised downward from $561.1 million to $556.4 million. Similarly, earnings estimates have been adjusted from $0.37 per share to $0.36 per share for the full year 2024, and from $0.86 per share to $0.84 per share for 2025.
Bioceres Crop Solutions Corp (BIOX, Financial) Reported History
In the previous quarter of March 31, 2024, Bioceres Crop Solutions Corp's (BIOX) actual revenue was $84 million, which missed analysts' revenue expectations of $98.5 million by -14.72%. Bioceres Crop Solutions Corp's (BIOX) actual earnings were $0.14 per share, which missed analysts' earnings expectations of $0.158 per share by -11.39%. After releasing the results, Bioceres Crop Solutions Corp (BIOX) was down by -2.83% in one day.
Bioceres Crop Solutions Corp (BIOX, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 5 analysts, the average target price for Bioceres Crop Solutions Corp (BIOX) is $18.6 with a high estimate of $25 and a low estimate of $15. The average target implies an upside of 83.98% from the current price of $10.11.
Based on GuruFocus estimates, the estimated GF Value for Bioceres Crop Solutions Corp (BIOX, Financial) in one year is $15.64, suggesting an upside of 54.7% from the current price of $10.11.
Based on the consensus recommendation from 5 brokerage firms, Bioceres Crop Solutions Corp's (BIOX, Financial) average brokerage recommendation is currently 1.8, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
